Industry experts again Fda authorization of molnupiravir, Merck’s COVID pill : Photographs

December 7, 2021 Vera

A COVID-19 antiviral capsule called molnupiravir from Merck and Ridgeback Biotherapeutics is currently being regarded by the Food stuff and Drug Administration for crisis use in the coronavirus pandemic.

Merck & Co Inc./Handout by way of Reuters

cover caption

toggle caption

Merck & Co Inc./Handout by way of Reuters

A panel of specialists advising the Food stuff and Drug Administration voted narrowly in favor of crisis use authorization of an antiviral tablet from Merck and Ridgeback Biotherapeutics to handle COVID-19.

The vote was 13 for and 10 in opposition to authorization. The Fda is not obligated to stick to the recommendations of its advisers but normally does.

If the company authorizes use of the drug, identified as molnupiravir, it would be the initially oral antiviral therapy for COVID-19 that could be taken at home. A second oral medicine from Pfizer, called Paxlovid, is also being considered for authorization by the Fda.

The Merck drug is taken 2 times a working day for 5 days and functions by producing a cascade of disabling mutations in the SARS-CoV-2 coronavirus through replication. The drug is meant for use by folks with delicate to reasonable sickness and who are at substantial danger of developing intense COVID-19. It is supposed to be taken inside of 5 times of signs and symptoms.

New antiviral drugs are coming for COVID. Here's what you need to know

An interim assessment of a clinical review of the drug identified that molnupiravir lower the possibility of hospitalization or demise in 50 %. Among the men and women who bought the drug, 7.1% finished up in the medical center or died, when compared with 14.1% who obtained the placebo. On the other hand, the last research examination released Friday confirmed only a 30% reduction in the danger of hospitalization or loss of life.

An Food and drug administration summary confirmed that in the next half of the examine, sufferers in the team handled with the drug were being more probable to be hospitalized or to die than those who got the placebo. The drug’s protection towards loss of life seen in the to start with 50 percent of the review didn’t maintain up in the 2nd fifty percent.

When requested about this discrepancy by committee chairperson Dr. Lindsey Baden, Dr. Nicholas Kartsonis, a Merck senior vice president, stated, “I really don’t have a satisfying answer to your query.”

The skill of the medicine to induce mutations outside of the virus, as noticed in some

CMS: Healthcare workers must get first COVID shot by Dec. 5 to continue Medicare, Medicaid participation

November 10, 2021 Vera

The Facilities for Medicare & Medicaid Providers (CMS) has issued its promised unexpected emergency regulation necessitating team working at healthcare services be vaccinated for COVID-19 as a affliction of participation in Medicare and Medicaid.

According to an announcement from the company, health care services must have a plan in place that ensures all qualified staff have obtained the first dose of a two-dose COVID-19 vaccine sequence or a a person-dose COVID-19 shot “prior to supplying any care, treatment or other companies” by Dec. 5. Qualified staff will then need to be completely vaccinated by Jan. 4, 2022.

“Ensuring patient safety and protection from COVID-19 has been the concentrate of our efforts in combatting the pandemic and the continuously evolving difficulties we’re observing,” CMS Administrator Chiquita Brooks-LaSure mentioned in a statement. “Today’s action addresses the danger of unvaccinated health and fitness treatment staff to patient basic safety and presents balance and uniformity across the nation’s health and fitness treatment process to strengthen the wellness of individuals and the providers who treatment for them.”

CMS claimed its new regulation necessitates health care services to establish a approach for exemptions based on health-related problems or religious grounds in accordance with federal law. The entire interim rule is 214 internet pages long and is scheduled to be revealed in the federal register Nov. 5.

Connected: Conflicting federal, condition COVID-19 vaccine needs have hospitals trapped in noncompliance

The agency claimed these demands will apply to around 76,000 suppliers and deal with much more than 17 million health care personnel across the U.S.

It plans to guarantee compliance with the COVID-19 vaccination prerequisites by way of a survey and enforcement course of action. Surveyors who decide a service provider or provider does not fulfill the needs will be cited as noncompliant be provided a grace time period to grow to be compliant “before supplemental steps come about,” the company mentioned.

“CMS’ goal is to convey healthcare vendors into compliance. Nonetheless, the agency will not hesitate to use its total enforcement authority to guard the overall health and safety of clients,” the company wrote in its announcement.

CMS claimed in the announcement that it has by now found an “encouraging” 9% uptick in nursing property workers vaccination costs considering the fact that asserting in excess of the summer season that team in all those services would be demanded to be vaccinated. The company also referenced a report

Nursing Home Residents Overlooked in Scramble for Covid Antibody Treatments

November 7, 2021 Vera

JoNel Aleccia, Kaiser Wellbeing Information

Of the dozens of clients Dr. Jim Yates has treated for covid-19 at his long-phrase care center in rural Alabama, this a single made him especially nervous.

The 60-12 months-previous male, who experienced been absolutely vaccinated, was diagnosed with a breakthrough an infection in late September. Nearly straight away, he essential supplemental oxygen, and lung exams confirmed ominous indicators of worsening disease. Yates, who is clinical director of Jacksonville Wellness and Rehabilitation, a competent nursing facility 75 miles northeast of Birmingham, realized his affected individual wanted extra powerful interventions — and quickly.

At the 1st signal of the man’s indications, Yates had placed an order with the Alabama Department of General public Well being for monoclonal antibodies, the lab-made proteins that mimic the body’s skill to combat the virus. But six days handed just before the vials arrived, almost missing the window in which the remedy performs best to avert hospitalization and demise.

“We’ve been pushing the limitations because of the time frame you have to go by,” Yates reported. “Fortunately, after we received it, he responded.”

Across the state, clinical administrators of skilled nursing and long-phrase treatment web pages say they’ve been scrambling to acquire doses of the potent antibody therapies pursuing a transform in federal policy that critics say limits materials for the vulnerable inhabitants of frail and elder people who stay at best danger of covid an infection even just after vaccination.

“There are men and women dying in nursing properties suitable now, and we never know irrespective of whether or not they could have been saved, but they did not have entry to the product,” said Chad Worz, CEO of the American Society of Guide Pharmacists, which signifies 1,500 pharmacies that serve extended-phrase care web-sites.

Just before mid-September, doctors and other vendors could get the antibody therapies straight by way of drug wholesaler AmerisourceBergen and acquire the doses inside 24 to 48 hrs. Even though early variations of the licensed treatments expected hourlong infusions administered at specialty centers or by properly trained team customers, a much more latest solution permits doses to be administered by way of injections, which have been fast adopted by push-thru clinics and nursing homes.

Prompt entry to the antibody therapies is critical because they perform by quickly cutting down the total of the virus in a person’s process, decreasing the likelihood of critical sickness. The therapies

Exercising Mental Fitness as We Move Forward with Our Covid Recovery

November 3, 2021 Vera

New York City (photo: Michael Appleton/Mayoral Photography Office)

In Southern California, three generations of a family gathered their separate households under one roof to weather the pandemic — and liked it so much they decided to make it permanent. On the Upper West Side of Manhattan, students organized to buy groceries and essentials for the housebound. And as the virus surged, a nationwide Brides’ magazine survey of engaged couples showed that 82% found the pandemic only made them keener to wed.

COVID-19, this nation’s deadliest pandemic, has taken the lives of over 700,000 Americans and about 4.5 million people worldwide. Everyone has been through some struggle – illness, grief over unimaginable loss, or the miasma of uncertainty about jobs, education, and daily routines. Amid tragedy and challenges, though, people have shown remarkable kindness. They have also forged new bonds, gained fresh insights into what it means to be there for others, and re-examined life priorities.

A Pew research survey of what it called the pandemic’s silver linings and struggles showed the clarity that came from being thrown together or living apart from loved ones and friends, and losing the underpinnings of everyday life, from office work to entertainment. The renowned economist Paul Krugman has even theorized that workers are quitting jobs at record rates in part because the pandemic has made them rethink their lives.

As we negotiate re-entry into work, school, socializing, and public spaces, plenty of us are dusting off that saying attributed to Winston Churchill: never let a good crisis go to waste. As an advocate for mental wellbeing, I do indeed believe that we can use these difficult days to foster personal growth and improve mental fitness.

By mental fitness I mean not just getting by or holding on. Rather, I define mental fitness as actively taking steps to achieve and maintain a state of wellbeing. Wellbeing means being more intentional: naming what we think, feel, and believe, and managing our emotions and behavior. We will all have ups and downs, but the more mentally fit we are, the more likely we are to weather a major life crisis or even a global pandemic.

Our level of mental fitness indicates whether we are able to draw on coping strategies that do not involve substance misuse, withdrawal, or hurting ourselves or others. The same way we work on toning our arms and legs and increasing our strength,

CDC advisers back Moderna and J&J COVID vaccine boosters : Shots

October 31, 2021 Vera

A health care worker administers a Pfizer-BioNTech COVID-19 vaccine Thursday at Life of Hope Center in New York City.

Michael M. Santiago/Getty Images

hide caption

toggle caption

Michael M. Santiago/Getty Images

A health care worker administers a Pfizer-BioNTech COVID-19 vaccine Thursday at Life of Hope Center in New York City.

Michael M. Santiago/Getty Images

The Centers for Disease Control and Prevention is backing the roll out of Moderna and Johnson & Johnson COVID-19 vaccine boosters in line with the Food and Drug Administration’s authorizations issued Wednesday. The CDC is also supporting a mix-and-match approach to booster vaccination.

CDC director Rochelle Walensky called the recommendations an “example of our fundamental commitment to protect as many people as possible from COVID-19.”

The announcement came just hours after the CDC’s vaccine advisory committee voted unanimously in favor of booster doses.

For Moderna, the panel said a booster should be given to people on the same terms as the Pfizer-BioNTech booster. That would cover people 65 and older, people 18 and older in long-term care settings and people 50 to 64 with relevant underlying medical conditions. The booster may be given to people 18 to 49 years with certain medical conditions and to people 18 to 64 who have COVID-19 risks related to their work or who live in certain institutional settings.

For Johnson & Johnson, the panel’s advice was simpler: A booster is recommended for people 18 and older at least two months after their initial immunization.

What to know about your risk of a serious or fatal breakthrough COVID infection

A CDC presentation and draft voting language said that the same vaccine used for initial immunization should be used as a booster dose but that a mix-and-match approach is OK when the primary vaccine isn’t available or a different vaccine is preferred.

During the committee discussions, several members pushed back against this preference for boosting with the same vaccine. They argued that a more permissive approach to mix-and-match would ease the administration of booster doses.

The FDA authorizes Moderna and J&J COVID vaccine boosters

After a brief break late in the deliberations, CDC staff returned with revised voting questions that were neutral on which vaccine should be used as a booster for the J&J and Moderna vaccines. The revised questions don’t explicitly mention which vaccine should be used as a booster, which clears the way for mix-and-match boosting without restrictions.

According to the CDC, more than 189 million people in the U.S. are fully vaccinated, about 57% of the population. Hospitalization rates are nine to

What the latest COVID research says about breakthrough cases and transmission : Shots

October 14, 2021 Vera

Gloria Clemons gives a COVID-19 vaccine to Navy veteran Perry Johnson at the Edward Hines, Jr. VA Hospital in Hines, Ill., in September.

Scott Olson/Getty Images

hide caption

toggle caption

Scott Olson/Getty Images

Gloria Clemons gives a COVID-19 vaccine to Navy veteran Perry Johnson at the Edward Hines, Jr. VA Hospital in Hines, Ill., in September.

Scott Olson/Getty Images

Conventional wisdom says that if you’re vaccinated and you get a breakthrough infection with the coronavirus, you can transmit that infection to someone else and make that person sick.

But new evidence suggests that even though that may happen on occasion, breakthrough infections might not represent the threat to others that scientists originally thought.

Ross Kedl, an immunologist at the University of Colorado School of Medicine, will point out to anyone who cares to listen that basic immunology suggests the virus of a vaccinated person who gets infected will be different from the virus of an infected unvaccinated person.

That’s because vaccinated people have already made antibodies to the coronavirus. Even if those antibodies don’t prevent infection, they still “should be coating that virus with antibody and therefore helping prevent excessive downstream transmission,” Kedl says. And a virus coated with antibodies won’t be as infectious as a virus not coated in antibodies.

Scant evidence for easy transmission of breakthrough infections

In Provincetown, Mass., this summer, a lot of vaccinated people got infected with the coronavirus, leading many to assume that this was an example of vaccinated people with breakthrough infections giving their infection to other vaccinated people.

Kedl isn’t convinced.

“In all these cases where you have these big breakthrough infections, there’s always unvaccinated people in the room,” he says.

In a recent study from Israel of breakthrough infections among health care workers, the researchers report that in “all 37 case patients for whom data were available regarding the source of infection, the suspected source was an unvaccinated person.”

How A Gay Community Helped The CDC Spot A COVID Outbreak — And Learn More About Delta

It’s hard to prove that an infected vaccinated person actually was responsible for transmitting their infection to someone else.

“I have seen no one report actually trying to trace whether or not the people who were vaccinated who got infected are downstream — and certainly only could be downstream — of another vaccinated person,” Kedl says.

There’s new laboratory evidence supporting Kedl’s supposition. Initially, most vaccine experts predicted that mRNA vaccines like the ones made by Pfizer and Moderna that are